On 9/16/24, Bausch Health Cos Inc (NYSE: BHC) stock enjoyed a major increase of 10.8%, closing at $7.00. Moreover, this advance was accompanied by unusually high trading volume at 162% of normal. Relative to the market the stock has been extremely weak over the last nine months but has risen 12.7% during the last week.
Current PriceTarget Research Rating
BHC is expected to be an important Value Eraser reflecting capital returns that are forecasted to fall short of the cost of capital.
Bausch Health is currently unrated.
Rating Review
The stock is currently unrated.
Be the first to comment